– Interview with Tomikazu Sasaki Ph.D., Associate Professor of Chemistry, University of Washington, and Co-Founder of Artemisia Biomedical, Inc.

Previous articleEnzyme Group May be Key to Chronic Leukemia
Next articleSpectrum Pharmaceuticals Forms JV with Cell Therapeutics to Jointly Market Oncology Drug